Larry Biegelsen
Stock Analyst at Wells Fargo
(3.73)
# 712
Out of 5,132 analysts
361
Total ratings
53.33%
Success rate
6.51%
Average return
Main Sectors:
Stocks Rated by Larry Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $93 → $98 | $95.61 | +2.50% | 11 | Feb 11, 2026 | |
| EW Edwards Lifesciences | Maintains: Overweight | $96 → $100 | $79.33 | +26.06% | 19 | Feb 11, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Overweight | $95 → $97 | $79.20 | +22.47% | 6 | Feb 5, 2026 | |
| BSX Boston Scientific | Maintains: Overweight | $125 → $94 | $73.47 | +27.94% | 16 | Feb 5, 2026 | |
| TFX Teleflex | Maintains: Equal-Weight | $139 → $116 | $106.95 | +8.46% | 9 | Jan 29, 2026 | |
| HTFL HeartFlow | Initiates: Overweight | $38 | $26.95 | +41.00% | 1 | Jan 28, 2026 | |
| JNJ Johnson & Johnson | Maintains: Overweight | $230 → $240 | $240.86 | -0.36% | 15 | Jan 22, 2026 | |
| PEN Penumbra | Downgrades: Equal-Weight | $374 | $338.26 | +10.57% | 20 | Jan 15, 2026 | |
| INSP Inspire Medical Systems | Maintains: Overweight | $160 → $145 | $68.21 | +112.58% | 15 | Jan 14, 2026 | |
| KMTS Kestra Medical Technologies | Maintains: Overweight | $27 → $28 | $27.85 | +0.54% | 3 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $72 → $82 | $83.05 | -1.26% | 20 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $114 | $101.08 | +12.78% | 19 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $452 → $456 | $363.70 | +25.38% | 17 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $17.03 | -0.18% | 9 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $95 | $81.32 | +16.82% | 12 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $13 → $14 | $19.66 | -28.79% | 11 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $9 → $10 | $8.03 | +24.53% | 15 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $98 → $93 | $68.15 | +36.46% | 10 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $120 → $122 | $109.03 | +11.90% | 17 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $599 → $600 | $496.12 | +20.94% | 21 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $0.68 → $0.85 | $1.10 | -22.73% | 6 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Equal-Weight | $93 | $79.39 | +17.14% | 9 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $3 | $1.45 | +106.90% | 7 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $24 | $22.27 | +7.77% | 17 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $40 → $15 | $10.50 | +38.10% | 18 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $17 | $14.54 | +16.92% | 1 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $40 → $49 | $11.18 | +338.28% | 2 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $136 | $113.59 | +19.73% | 21 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $70 | $88.26 | -20.69% | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $270 | $180.62 | +49.49% | 5 | Apr 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $67.28 | - | 2 | Nov 2, 2017 |
Zimmer Biomet Holdings
Feb 11, 2026
Maintains: Equal-Weight
Price Target: $93 → $98
Current: $95.61
Upside: +2.50%
Edwards Lifesciences
Feb 11, 2026
Maintains: Overweight
Price Target: $96 → $100
Current: $79.33
Upside: +26.06%
GE HealthCare Technologies
Feb 5, 2026
Maintains: Overweight
Price Target: $95 → $97
Current: $79.20
Upside: +22.47%
Boston Scientific
Feb 5, 2026
Maintains: Overweight
Price Target: $125 → $94
Current: $73.47
Upside: +27.94%
Teleflex
Jan 29, 2026
Maintains: Equal-Weight
Price Target: $139 → $116
Current: $106.95
Upside: +8.46%
HeartFlow
Jan 28, 2026
Initiates: Overweight
Price Target: $38
Current: $26.95
Upside: +41.00%
Johnson & Johnson
Jan 22, 2026
Maintains: Overweight
Price Target: $230 → $240
Current: $240.86
Upside: -0.36%
Penumbra
Jan 15, 2026
Downgrades: Equal-Weight
Price Target: $374
Current: $338.26
Upside: +10.57%
Inspire Medical Systems
Jan 14, 2026
Maintains: Overweight
Price Target: $160 → $145
Current: $68.21
Upside: +112.58%
Kestra Medical Technologies
Dec 12, 2025
Maintains: Overweight
Price Target: $27 → $28
Current: $27.85
Upside: +0.54%
Dec 5, 2025
Maintains: Equal-Weight
Price Target: $72 → $82
Current: $83.05
Upside: -1.26%
Nov 19, 2025
Maintains: Overweight
Price Target: $100 → $114
Current: $101.08
Upside: +12.78%
Nov 14, 2025
Maintains: Overweight
Price Target: $452 → $456
Current: $363.70
Upside: +25.38%
Nov 14, 2025
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $17.03
Upside: -0.18%
Nov 14, 2025
Maintains: Overweight
Price Target: $103 → $95
Current: $81.32
Upside: +16.82%
Nov 7, 2025
Maintains: Equal-Weight
Price Target: $13 → $14
Current: $19.66
Upside: -28.79%
Nov 6, 2025
Maintains: Equal-Weight
Price Target: $9 → $10
Current: $8.03
Upside: +24.53%
Oct 31, 2025
Maintains: Overweight
Price Target: $98 → $93
Current: $68.15
Upside: +36.46%
Oct 30, 2025
Maintains: Overweight
Price Target: $120 → $122
Current: $109.03
Upside: +11.90%
Oct 22, 2025
Maintains: Overweight
Price Target: $599 → $600
Current: $496.12
Upside: +20.94%
Aug 15, 2025
Maintains: Equal-Weight
Price Target: $0.68 → $0.85
Current: $1.10
Upside: -22.73%
Aug 6, 2025
Reinstates: Equal-Weight
Price Target: $93
Current: $79.39
Upside: +17.14%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $6 → $3
Current: $1.45
Upside: +106.90%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $33 → $24
Current: $22.27
Upside: +7.77%
Jul 25, 2025
Downgrades: Equal-Weight
Price Target: $40 → $15
Current: $10.50
Upside: +38.10%
Jan 30, 2025
Maintains: Overweight
Price Target: $13 → $17
Current: $14.54
Upside: +16.92%
Dec 5, 2023
Upgrades: Overweight
Price Target: $40 → $49
Current: $11.18
Upside: +338.28%
Apr 5, 2023
Maintains: Overweight
Price Target: $140 → $136
Current: $113.59
Upside: +19.73%
May 11, 2022
Maintains: Overweight
Price Target: $80 → $70
Current: $88.26
Upside: -20.69%
Apr 8, 2020
Maintains: Overweight
Price Target: $279 → $270
Current: $180.62
Upside: +49.49%
Nov 2, 2017
Upgrades: Outperform
Price Target: n/a
Current: $67.28
Upside: -